• Something wrong with this record ?

Novel strategy in the treatment of liver metastases - Hepatic resection combined with stereotactic body radiotherapy

P. Ihnát, E. Skácelíková, P. Vávra, T. Jonszta, L. Ihnát Rudinská, H. Tomášková,

. 2020 ; 43 (9) : 902-906. [pub] 20200103

Language English Country China

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc20027864

BACKGROUND: To evaluate the safety, feasibility and outcomes of patients treated for colorectal liver metastases (CLM) with an innovative combined approach - hepatic resection and Stereotactic body radiotherapy (SBRT) using CyberKnife® system. METHODS: This was a retrospective cohort study conducted in a single institution. Patients with CLM and no evidence of extrahepatic disease were included during a 6-year study period. RESULTS: In total, 19 patients with 63 liver lesions underwent liver resection combined with SBRT of unresectable lesions. Major hepatectomy was performed in 42.1% patients; postoperative complications were noted in 31.6% patients. 27 unresectable lesions were treated by SBRT with a total dose of 50-60 Gy in five fractions. The median follow-up of study patients was 29.7 ± 20.58 months. Local control of CLM at 1 and 2 years was achieved in 89.5% of patients. Out-of-field hepatic recurrence was diagnosed in 63.1% patients. The 1-year disease-free survival (DFS) was 52.6%; 2-year DFS was 31.6%. The overall actuarial survival rates at 1 and 2 years were 88.2% and 50.4%. CONCLUSION: Liver resection combined with SBRT presents a promising therapeutic option for patients with CLM which traditionally are unresectable. The additional use of SBRT allows for the effective clearance of the disease for thoroughly selected patients.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20027864
003      
CZ-PrNML
005      
20210114152521.0
007      
ta
008      
210105s2020 cc f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.asjsur.2019.11.016 $2 doi
035    __
$a (PubMed)31911035
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a cc
100    1_
$a Ihnát, Peter $u Department of Surgery, University Hospital Ostrava, 17.listopadu 1790, Ostrava, 708 52, Czech Republic; Department of Surgical Studies, Faculty of Medicine, University of Ostrava, Syllabova 19, Ostrava, 703 00, Czech Republic. Electronic address: peterihnat@yahoo.com.
245    10
$a Novel strategy in the treatment of liver metastases - Hepatic resection combined with stereotactic body radiotherapy / $c P. Ihnát, E. Skácelíková, P. Vávra, T. Jonszta, L. Ihnát Rudinská, H. Tomášková,
520    9_
$a BACKGROUND: To evaluate the safety, feasibility and outcomes of patients treated for colorectal liver metastases (CLM) with an innovative combined approach - hepatic resection and Stereotactic body radiotherapy (SBRT) using CyberKnife® system. METHODS: This was a retrospective cohort study conducted in a single institution. Patients with CLM and no evidence of extrahepatic disease were included during a 6-year study period. RESULTS: In total, 19 patients with 63 liver lesions underwent liver resection combined with SBRT of unresectable lesions. Major hepatectomy was performed in 42.1% patients; postoperative complications were noted in 31.6% patients. 27 unresectable lesions were treated by SBRT with a total dose of 50-60 Gy in five fractions. The median follow-up of study patients was 29.7 ± 20.58 months. Local control of CLM at 1 and 2 years was achieved in 89.5% of patients. Out-of-field hepatic recurrence was diagnosed in 63.1% patients. The 1-year disease-free survival (DFS) was 52.6%; 2-year DFS was 31.6%. The overall actuarial survival rates at 1 and 2 years were 88.2% and 50.4%. CONCLUSION: Liver resection combined with SBRT presents a promising therapeutic option for patients with CLM which traditionally are unresectable. The additional use of SBRT allows for the effective clearance of the disease for thoroughly selected patients.
650    _2
$a karcinom $x mortalita $x sekundární $x chirurgie $7 D002277
650    _2
$a kohortové studie $7 D015331
650    _2
$a kolorektální nádory $x patologie $7 D015179
650    _2
$a studie proveditelnosti $7 D005240
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a hepatektomie $x metody $7 D006498
650    _2
$a lidé $7 D006801
650    _2
$a nádory jater $x mortalita $x sekundární $x chirurgie $7 D008113
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a pooperační komplikace $x epidemiologie $7 D011183
650    _2
$a radiochirurgie $x metody $7 D016634
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a míra přežití $7 D015996
650    _2
$a výsledek terapie $7 D016896
650    _2
$a senioři $7 D000368
655    _2
$a časopisecké články $7 D016428
700    1_
$a Skácelíková, Eva $u Department of Oncology, University Hospital Ostrava, 17.listopadu 1790, Ostrava, 708 52, Czech Republic.
700    1_
$a Vávra, Petr $u Department of Surgery, University Hospital Ostrava, 17.listopadu 1790, Ostrava, 708 52, Czech Republic; Department of Surgical Studies, Faculty of Medicine, University of Ostrava, Syllabova 19, Ostrava, 703 00, Czech Republic.
700    1_
$a Jonszta, Tomáš $u Department of Radiology, University Hospital Ostrava, 17.listopadu 1790, Ostrava, 708 52, Czech Republic.
700    1_
$a Ihnát Rudinská, Lucia $u Department of Forensic Medicine, University Hospital Ostrava, 17.listopadu 1790, Ostrava, 708 52, Czech Republic.
700    1_
$a Tomášková, Hana $u Department of Epidemiology and Public Health, Faculty of Medicine, University of Ostrava, Syllabova 19, Ostrava, 703 00, Czech Republic.
773    0_
$w MED00005710 $t Asian journal of surgery $x 0219-3108 $g Roč. 43, č. 9 (2020), s. 902-906
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31911035 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20210114152519 $b ABA008
999    __
$a ok $b bmc $g 1608199 $s 1119044
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 43 $c 9 $d 902-906 $e 20200103 $i 0219-3108 $m Asian journal of surgery $n Asian J Surg $x MED00005710
LZP    __
$a Pubmed-20210105

Find record

Citation metrics

Archiving options